Literature DB >> 28711816

Unilateral subthalamotomy in Parkinson's disease: Cognitive, psychiatric and neuroimaging changes.

Ignacio Obeso1, Enrique Casabona2, Rafael Rodríguez-Rojas3, Maria Luisa Bringas2, Raúl Macías2, Nancy Pavón2, Jose A Obeso3, Marjan Jahanshahi4.   

Abstract

Unilateral subthalamotomy is an effective treatment for the cardinal motor features of Parkinson's disease (PD). However, non-motor changes possibly associated with right or left subthalamotomy remain unknown. Our aim was to assess cognitive, psychiatric and neuroimaging changes after treatment with unilateral subthalamotomy. Fourteen medicated patients with PD were evaluated before and after (mean 6 months after operation) unilateral subthalamotomy (5 right, 9 left). In addition to motor assessments, cognitive (global cognition and executive functions), psychiatric (apathy, depression, anxiety, mania, hypo- and hyperdopaminergic behaviours, impulsivity), quality of life evaluations and volume of lesions were obtained. After surgery, significant improvement of motor signs was observed. Unilateral subthalamotomy improved general cognitive status, but left subthalamotomy reduced semantic verbal fluency compared to the pre-operative state. Depression and quality of life were improved with both right and left subthalamotomy. However, hyper-emotionality was present after surgery and right subthalamotomy increased impulsivity and disinhibition (on NeuroPsychiatric Inventory and Ardouin Scale for Behaviour in PD), a result linked to larger lesion volumes. We conclude that unilateral subthalamotomy is effective for treating the cardinal motor features of PD and improves mood. Right subthalamotomy is associated with greater risk of impulsivity and disinhibition, while left subthalamotomy induces further impairment of semantic verbal fluency.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Basal ganglia; Disinhibition; Impulsivity; Subthalamic nucleus; Subthalamotomy

Mesh:

Year:  2017        PMID: 28711816     DOI: 10.1016/j.cortex.2017.06.006

Source DB:  PubMed          Journal:  Cortex        ISSN: 0010-9452            Impact factor:   4.027


  5 in total

1.  The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson's disease patients.

Authors:  Tommaso Nuzzo; Daniela Punzo; Paola Devoto; Elena Rosini; Silvia Paciotti; Silvia Sacchi; Qin Li; Marie-Laure Thiolat; Celine Véga; Massimo Carella; Manolo Carta; Fabrizio Gardoni; Paolo Calabresi; Loredano Pollegioni; Erwan Bezard; Lucilla Parnetti; Francesco Errico; Alessandro Usiello
Journal:  Sci Rep       Date:  2019-06-20       Impact factor: 4.379

2.  A Computational Model of Loss of Dopaminergic Cells in Parkinson's Disease Due to Glutamate-Induced Excitotoxicity.

Authors:  Vignayanandam Ravindernath Muddapu; Alekhya Mandali; V Srinivasa Chakravarthy; Srikanth Ramaswamy
Journal:  Front Neural Circuits       Date:  2019-02-25       Impact factor: 3.492

3.  The Influence of Aging on the Functional Connectivity of the Human Basal Ganglia.

Authors:  Clara Rodriguez-Sabate; Ingrid Morales; Manuel Rodriguez
Journal:  Front Aging Neurosci       Date:  2022-01-12       Impact factor: 5.750

4.  Alpha-Synuclein: The Spark That Flames Dopaminergic Neurons, In Vitro and In Vivo Evidence.

Authors:  Alexandre Henriques; Laura Rouvière; Elodie Giorla; Clémence Farrugia; Bilal El Waly; Philippe Poindron; Noëlle Callizot
Journal:  Int J Mol Sci       Date:  2022-08-30       Impact factor: 6.208

5.  Menopausal Women's Health Care Method Based on Computer Nursing Diagnosis Intelligent System.

Authors:  Qing Chao; Weiping Ma; RuiJia Xu; Lingyan Wu; Youwen Zhang; Miao He; Ke Yang; Wanxia Yao; Rong Peng
Journal:  J Healthc Eng       Date:  2021-07-24       Impact factor: 2.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.